课题基金 / 基金详情

METH-induced T cell Dysfunction: Role in HIV-1 Immunopathogenesis

METH-induced T cell Dysfunction: Role in HIV-1 Immunopathogenesis
METH 诱导的 T 细胞功能障碍:在 HIV-1 免疫发病机制中的作用
批准号:
7556633
负责人:
Raghava Potula
金额:
$22.5万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-15 至 2010-08-31
关键词:
3-nitrotyrosine76-kDa SH2 domain-containing leukocyte proteinAcetatesAdaptor Signaling ProteinAddressAffectAlcohol abuseAmericanAnimal ModelAntigensAntioxidantsApplications GrantsBiological AssayBiological MarkersCD3 AntigensCD8B1 geneCell Differentiation processCell ProliferationCell physiologyCell surfaceCellsCentral Nervous System InfectionsChronicCommunicable DiseasesConditionCultured CellsCytokine GeneCytotoxic T-LymphocytesDNADataDefectDisease ProgressionDistalEncephalitisEnzyme-Linked Immunosorbent AssayEpidemiologic StudiesEventExtracellular Signal Regulated KinasesFlow CytometryFunctional disorderGene ChipsGene ExpressionGenerationsGenesGlutathioneHIVHIV InfectionsHIV-1Host resistanceHumanIllicit DrugsImmuneImmune Cell ActivationImmune System DiseasesImmune responseImmune systemImmunityImmunosuppressionIn VitroIncidenceInfectionInflammationInterferonsInterleukin-10Interleukin-2Interleukin-4InvestigationIonomycinLCP2 geneLeadLevocarnitine AcetylLinkLipidsLongevityMeasuresMediatingMembrane PotentialsMembrane ProteinsMethamphetamineMicroarray AnalysisMitochondriaMitogen-Activated Protein KinasesModelingMolecularMolecular ProfilingMonoclonal Antibody HuM291Morbidity - disease rateMuromonab-CD3NF-ATNeuraxisNitric OxideOrganOxidative StressPathway interactionsPeripheralPharmaceutical PreparationsPhosphorylationPlayPolymerase Chain ReactionPopulationPredispositionProductionProteinsPublic HealthRNAReactionReactive Oxygen SpeciesReceptor ActivationReceptor SignalingRegulationResortResveratrolReverse Transcriptase Polymerase Chain ReactionRoleSamplingSerumSignal PathwaySignal TransductionSignaling MoleculeSplenocyteStaining methodStainsStudy modelsSystemT Cell Receptor Signaling PathwayT-Cell ActivationT-Cell ProliferationT-Cell ReceptorT-LymphocyteTestingTherapeuticThinkingTimeTissuesTranscriptional ActivationTransforming Growth FactorsTranslatingTumor Necrosis Factor-alphaTumor Necrosis FactorsViralViral Load resultVirusWestern BlottingWorkZAP-70 Geneastrogliosisbasecatalasecell mediated immune responsechemokineclinically significantconceptcrosslinkcytokinecytotoxicdesigndrug abuserfunctional statusgranzyme Bhuman MAPK14 proteinhuman TNF proteinimmune functionimprovedin vivoinhibitor/antagonistinsightinterestkinase inhibitormacrophagemethamphetamine exposureneuroinflammationneuropathologyneurotoxicitynovelnuclear factors of activated T-cellsperforinphorbol-12-myristatepreventpsychostimulantresponsestimulant abusestress-activated protein kinase 1transcription factor

项目摘要

项目成果

Raghava Potula的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Illicit drugs such as methamphetamine (METH) alter immune functions and decreases host resistance. There is an association between METH abuse and enhanced susceptibility to infections; however, underlying mechanisms are largely unknown. High incidence of HIV-1 infection in METH abusers and potential effects of METH on immune system underscore clinical significance of METH-HIV-1 co-morbidity. Defective immune responses could lead to the accelerated HIV-1 infection in the peripheral organs and central nervous system (CNS). Preliminary data point to the oxidative stress as one of possible causes of METH induced immune dysfunction. Indeed, our preliminary studies indicate that METH exposure elicits oxidative stress in T cells and upon T-cell receptor stimulation show T cell proliferation and decreases cytokine production. T cells exposed to METH demonstrate modulation of genes controlling in immune cell activation and T cell surface markers. Therefore, we hypothesize that the oxidative stress caused by METH in T lymphocytes dampens immune responses, impairs T cell activation and proliferation leading to enhanced progression of HIV-1 infection. Using a combination of in vitro systems and animal model for HIV-1 encephalitis chronically exposed to METH, we will address the following questions: (1) What are the potential implications of METH- induced oxidative stress on T cell functions? (2) What are the mechanisms underlying impaired T cell immune responses mediated by oxidative stress associated with METH? (3) How does T cell dysfunction affect the adaptive immune system responses to HIV-1 infection in and outside of CNS? Antioxidants and specific signaling inhibitors will be utilized to delineate pathways involved in these effects. We believe that the proposed works are highly significant as they will uncover novel mechanisms mediating combined effects of HIV-1 and METH abuse on immunity and propose therapeutic approaches based on these investigations. PUBLIC HEALTH RELEVANCE Methamphetamine is a highly addictive stimulant abused by millions of Americans and is known to alter immune function and increase susceptibility to infection. Epidemiological studies indicate growing evidence of the association between METH abuse and an increased incidence of HIV-1 infections. However, the apparent causal interrelationship between METH abuse and susceptibility to HIV-1 infection or its progression are largely unknown. This proposal aims to understand putative mechanisms of immune dysfunctions in the setting of METH abuse and HIV-1 infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV
  • 批准号:
    10434933
  • 项目类别:
  • 资助金额:
    $45.32万
  • 财政年份:
    2018
  • 负责人:
    Raghava Potula
  • 依托单位:
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV
  • 批准号:
    9930925
  • 项目类别:
  • 资助金额:
    $0.85万
  • 财政年份:
    2018
  • 负责人:
    Raghava Potula
  • 依托单位:
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV
  • 批准号:
    9788407
  • 项目类别:
  • 资助金额:
    $53.41万
  • 财政年份:
    2018
  • 负责人:
    Raghava Potula
  • 依托单位:
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV
  • 批准号:
    10251003
  • 项目类别:
  • 资助金额:
    $53.41万
  • 财政年份:
    2018
  • 负责人:
    Raghava Potula
  • 依托单位: